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ABSTRACT 27 
Purpose. This study aimed to (i) explore children’s compliance to wearing wrist and hip-28 
mounted accelerometers, (ii) compare children’s physical activity (PA) derived from wrist and 29 
hip raw accelerations, and (iii) examine differences in raw and counts PA measured by hip-30 
worn accelerometry.  31 
Methods. One hundred and twenty nine 9-10 y old children wore a wrist-mounted GENEActiv 32 
accelerometer (GAwrist) and a hip-mounted ActiGraph GT3X+ accelerometer (AGhip) for 7 33 
d. Both devices measured raw accelerations and the AGhip also provided counts-based data.  34 
Results. More children wore the GAwrist than the AGhip regardless of wear time criteria 35 
applied (p<.001 - .035). Raw data signal vector magnitude (SVM; r = .68), moderate PA (MPA; 36 
r = .81), vigorous PA (VPA; r = .85), and moderate-to-vigorous PA (MVPA; r = .83) were 37 
strongly associated between devices (p<.001). GAwrist SVM (p = .001), MPA (p = .037), VPA 38 
(p = .002), and MVPA (p = .016) were significantly greater than AGhip. According to GAwrist 39 
raw data, 86.9% of children engaged in at least 60 min MVPA∙d-1, compared to 19% for AGhip. 40 
ActiGraph MPA (raw) was 41.93 ± 1.66 min∙d-1 compared to 35.26 ± 1.01 min∙d-1 (counts) 41 
(p=.02). Actigraph VPA was 7.63 ± 0.47 min∙d-1 (raw) and 37.45 ± 1.87 min∙d-1 (counts; 42 
p=.52).  43 
Conclusion. In children accelerometer wrist placement promotes superior compliance than the 44 
hip. Raw accelerations were significantly higher for GAwrist compared to AGhip, possibly due 45 
to placement location and technical differences between devices. AGhip PA calculated from 46 
raw accelerations and counts differed substantially, demonstrating that PA outcomes derived 47 
from cutpoints for raw output and counts cannot be directly compared. Raw acceleration data 48 
processing potentially allows for greater transparency and comparability between studies, but 49 
presently, comparisons with counts-based data are limited. 50 
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INTRODUCTION 53 
Accelerometry is the most widely used objective method of assessing children’s free-living 54 
physical activity (PA) (2). Accelerometers allow accelerations to be quantified, and in the 55 
context of PA research the accelerometer outcome is related to a measure of energy expenditure 56 
(13) or PA behaviour (19). Traditionally, accelerometers have been worn on the hip as this 57 
location is thought to provide the most accurate estimations of energy expenditure and activity 58 
intensity (28). Recently there has been an increased use of wrist-worn devices, which it has 59 
been argued, promote better compliance to device wear.  In the NHANES 2011-12 data 60 
collection cycle using wrist-worn accelerometers, median wear time duration was 21-22 hours 61 
per day, which was up to 100% longer than in previous cycles using hip-worn devices (30). 62 
Compared to hip-worn accelerometers, those worn on the wrist may be perceived as less 63 
burdensome to research participants, thus promoting wear-time compliance (23, 39). Variable 64 
compliance to accelerometer monitoring protocols influences the application of minimum wear 65 
time criteria (i.e., number of minutes wear that constitutes a ‘valid’ day of measurement and 66 
the minimum number of days required for a reliable estimate of PA levels), which are subject 67 
to variation in researcher decisions about how ‘non-wear’ time is defined (35). Better 68 
compliance gives greater confidence that PA data are representative of actual daily PA due to 69 
the association between duration of monitoring and reliability of PA data (17). Presently 70 
though, there is limited evidence of the extent of improved compliance in children wearing 71 
accelerometers on the wrist.  72 
The growing popularity of the wrist as the accelerometer placement site warrants comparisons 73 
with PA data derived from devices worn on the hip, which has traditionally been the most 74 
commonly used site. Recently, PA intensity cutpoints derived from raw acceleration output 75 
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have been developed in the same study for the GENEActiv (Activinsights, Cambs, UK) and 76 
ActiGraph GT3X+ (ActiGraph, Pensacola, FL) accelerometers, which are designed for wear 77 
both on the wrist and hip (13).  Using these protocol-specific cutpoints together may help 78 
improve our understanding of how concurrent estimates of PA intensity from the wrist and hip 79 
sites compare. This move towards raw acceleration signal processing is a recent advance in 80 
accelerometer-based PA monitoring, which has traditionally used accelerometer output 81 
reduced to ‘counts’. Direct comparison of PA outcomes derived from different devices has not 82 
previously been possible due to differences in proprietary algorithms used to collect, process, 83 
filter, and scale raw signal data to produce the device-specific counts (4, 40). This lack of 84 
equivalency between devices and therefore comparability between studies using different 85 
devices, has led to the emergence of accelerometers such as the GENEActiv and ActiGraph 86 
GT3X+ and GT9X, that are capable of collecting and recording raw, unfiltered accelerations 87 
which can then be subject to researcher-driven data processing procedures (40). Basing PA 88 
data on raw accelerations provides an opportunity to improve comparability between studies 89 
using different devices, and promote transparency and consistency of post-data collection 90 
analytical processes (13). Presently though, limited published research is available describing 91 
children’s free-living PA derived from raw accelerometer data. One study involving  47, 1st to 92 
5th grade children wearing GENEActiv accelerometers on the wrist reported mean daily MVPA 93 
and VPA of 308.2 min and 32.7 min, respectively (33). In a sample of 58 Australian 10-12 year 94 
olds, MVPA from GENEActiv raw data was 67.8 min∙d-1 (hip) and 98.2 min∙d-1 (wrist) with 95 
VPA recorded as 11.1 min∙d-1 (hip) and 16.7 min∙d-1 (wrist) (30). These studies however, 96 
calculated the signal vector magnitude values differently (i.e., averaging vs. summing raw 97 
accelerations per epoch), and used different PA intensity cutpoints (25, 33), which makes direct 98 
comparison of findings challenging. Another important issue is that historical accelerometer 99 
data used counts and extensive validation work has been conducted on counts-based 100 
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accelerometer data (10, 19, 26, 37). Although the ‘cutpoint conundrum’ exists, there has been 101 
some consensus in recent years for using the cutpoints of Evenson et al. (10), which have 102 
convincing evidence of validity in children (36). These cutpoints therefore provide a basis for 103 
free-living comparison with more contemporary cutpoints based on raw accelerations (13, 25, 104 
33).  105 
As the field moves more towards utilisation of raw data processing and the availability of wrist-106 
worn devices increases, studies reporting the comparability of PA outcomes based on raw 107 
accelerations and counts from both wrist and hip are warranted. Therefore, the aims of this 108 
study were (i) to explore children’s compliance to wearing wrist and hip-mounted 109 
accelerometers during free-living, (ii) to compare children’s PA derived from raw acceleration 110 
signals of wrist and hip worn accelerometers, and (iii) to examine differences in PA estimated 111 
from raw data with that from counts data measured by a hip worn accelerometer. 112 
METHODS 113 
Participants. The participants were 129 Year 5 (9-10 y) children (79 girls) from six primary 114 
schools in Liverpool, England. Following ethical approval from the University Research Ethics 115 
Committee, all Year 5 children (n = 326) in participating schools were invited to participate. 116 
They received a pack which contained parent and child information sheets, consent and assent 117 
forms, and a medical screening form. Written informed consent and assent was received from 118 
parents and their children, respectively before children could participate in the study. 119 
Anthropometrics. Stature and sitting stature were assessed to the nearest 0.1cm using a portable 120 
stadiometer (Leicester Height Measure, Seca, Birmingham, UK). Body mass was assessed to 121 
the nearest 0.1kg (Seca, Birmingham, UK). Body mass index (BMI) was calculated for each 122 
participant with BMI z-scores also assigned (5). Age and sex specific BMI cut points were used 123 
to classify children as normal weight or overweight/obese (6). Gender-specific regression 124 
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equations (22) were used to predict children’s age from peak height velocity (APHV), which 125 
is a proxy measure of biological maturation. All measurements were taken by the second author 126 
and a research assistant using standard procedures (18). 127 
Socio-economic status. Neighbourhood-level socio-economic status (SES) was calculated 128 
using the 2010 Indices of Multiple Deprivation (IMD) (8). The IMD is a UK Government 129 
produced measure comprising seven areas of deprivation (income, employment, health, 130 
education, housing, environment, and crime). Deprivation scores were generated using the 131 
National Statistics Postcode Directory database from parent reported home postcodes. Higher 132 
SES was represented by lower IMD scores. 133 
Physical Activity. Free-living PA was assessed using the GENEActiv triaxial accelerometer 134 
(Activinsights, Cambs, UK) worn on the non-dominant wrist (GAwrist) and the ActiGraph 135 
GT3X+ triaxial accelerometer (ActiGraph, Pensacola, FL) worn on the right hip (AGhip). The 136 
GENEActiv can be worn on the wrist, upper arm, hip, chest, ankle, and thigh, has a dynamic 137 
range of ± 8 g, and is a valid measure of PA in children (13, 25, 33). The GENEActiv was 138 
selected because it measures raw accelerations and is typically worn on the wrist (1). ActiGraph 139 
accelerometers have been used in PA research for around 20 years and have been validated on 140 
several occasions with children (10, 21, 26, 37). The GT3X+ model has a dynamic range of ± 141 
6 g, and can be worn on the hip, ankle, wrist, and thigh. The ActiGraph was selected as it is the 142 
most commonly used accelerometer in children’s PA research, and though it is being worn on 143 
the wrist in the most recent NHANES data collection phases (30), traditionally it has been worn 144 
on the hip (28). The GT3X+ has the capability to generate raw acceleration and count data to 145 
enable straightforward backwards interpretation of data in either format. Both devices were 146 
initialised to record raw accelerations at a frequency of 100 Hz, and participants were asked to 147 
wear the monitors at all times for 7 consecutive days except when sleeping and engaging in 148 
water based activities (e.g., bathing, swimming). Data collection took place during the regular 149 
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school term from January to May 2014 so activities were representative of usual free-living 150 
activities. After 7 days GAwrist data were downloaded using GENEActiv v.2.2 software 151 
(Activinsights, Cambs, UK) and saved in raw format as binary files. AGHip data were 152 
downloaded using ActiLife v. 6.11.4 (ActiGraph, Pensacola, FL) and saved in raw format as 153 
GT3X files. These were subsequently converted to CSV format to facilitate raw data 154 
processing, and to AGD format for analysis of counts data. GAwrist and AGhip raw data files 155 
were then processed in R (http://cran.r-project.org) using the GGIR package (version 1.1-4) 156 
which converted raw triaxial acceleration values into one omnidirectional measure of 157 
acceleration, termed the signal vector magnitude (SVM). SVM was calculated from raw 158 
accelerations from the three axes minus 1 g which represents the value of gravity (i.e., SVM = 159 
√(x2 + y2 + z2) – 1), after which negative values were rounded to zero. This metric has 160 
previously been referred to as the Euclidean norm minus one (ENMO) (38). Raw data were 161 
further reduced by calculating the average SVM values per 1-s epoch expressed in mg∙s-1 over 162 
each of the 7 monitored days. 163 
 164 
AGhip and GAwrist raw data wear times were estimated on the basis of the standard deviation 165 
and value range of each axis, calculated for 60 min moving windows with 15 min increments 166 
(38). A time window was classified as nonwear time if, for at least 2 out of the 3 axes, the 167 
standard deviation was less than 13.0 mg or if the value range was less than 50 mg (32). This 168 
approach has been applied previously in studies using both devices worn at the wrist and hip 169 
(29, 30, 38). For ActiGraph counts data, non-wear is conventionally determined from 170 
accumulated pre-determined time periods of consecutive zero counts. To address study aim 3, 171 
and in keeping with previous work (11, 27), the 1-s epoch AGhip counts data non-wear time 172 
was defined as at least 20 min periods of consecutive zero counts (3). 173 
 174 
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Raw acceleration outcome variables for AGhip and GAwrist were average gravity-based SVM 175 
(mg), and min of MPA, VPA, and MVPA which were calculated using device and location-176 
specific cutpoints based on the ENMO metric (13). These were 142.6 mg (MPA) and 464.6 mg 177 
(VPA) for AGhip, and 191.6 mg (MPA) and 695.8 mg (VPA) for GAwrist (13). Comparing 178 
PA values based on ENMO-derived SVM was important as this metric was applied to 179 
ActiGraph GT3X+ and GENEActiv  data in the same calibration study (13). For analysis of 180 
raw acceleration and counts-based PA levels, inclusion criteria were at least 10 h∙day-1 wear 181 
time for at least three days, including a minimum of one weekend day. This resulted in 182 
analytical samples of 84 participants for the GAwrist vs. AGhip raw data analyses, and 65 183 
participants for the AGhip raw vs. counts data analyses. Outcome variables for AGhip counts 184 
data were min of MPA, VPA, and MVPA which were classified according to empirical 185 
cutpoints (10) that have demonstrated acceptable classification accuracy across a range of 186 
intensities in children (36). Presently, no published sedentary time cutpoints exist for GAwrist 187 
and AGhip raw accelerations calculated using the ENMO approach. For this reason we did not 188 
investigate differences in sedentary time and light intensity PA. 189 
 190 
Analysis. Kolmogorov-Smirnov tests confirmed that raw PA outcome data for the overall week 191 
and week days were normally distributed but that weekend GAwrist SVM and VPA, weekend 192 
AGhip SVM, MVPA, and VPA, and AGhip counts data had skewed distributions (p<.05). 193 
Following log (SVM, MVPA), square root (VPA), and reciprocal (AGhip counts MPA, VPA, 194 
MVPA) transformations, data were normalized and included for analyses. All transformed data 195 
were back-transformed for presentation purposes. To analyse compliance (study aim 1), mean 196 
daily valid wear time and number of valid days were calculated for GAwrist and AGhip raw 197 
data. Paired samples McNemar’s tests and t-tests assessed compliance and wear time 198 
differences against differing wear time criteria. To address study aim 2, partial Pearson 199 
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correlation analyses assessed raw data relationships between devices for SVM, MPA, VPA, 200 
and MVPA, while controlling for the effects of wear time. Bland-Altman plots were 201 
constructed to assess agreement between device raw data outputs, and repeated measures 202 
ANCOVAs compared raw data PA outcomes between AGhip and GAwrist for the whole week, 203 
week days, and weekend days.  For aim 3, repeated measures ANCOVAs examined differences 204 
in whole week reciprocal transformed MPA, VPA, and MVPA between AGhip raw and counts 205 
data. In each ANCOVA adjustment was made for device wear time and sex. Statistical 206 
significance was set to p<.05. All analyses were conducted using IBM SPSS Statistics version 207 
22 (IBM, Armonk, NY). 208 
RESULTS 209 
Descriptive characteristics of the participants are displayed in Table 1. Around three-quarters 210 
of the children were of healthy weight which is typical for Liverpool but somewhat lower than 211 
the English national average. Boys and girls were similarly aged but girls were more advanced 212 
than boys in regards to somatic maturation. IMD scores indicated that participants resided in 213 
some of the lowest SES neighbourhoods in England.  214 
TABLE 1 HERE 215 
Raw data device compliance  216 
AGhip and GAwrist data were available for 115 and 128 children, respectively. Instances of 217 
device malfunction orsoftware errors, and accelerometer non-wear accounted for the modest 218 
data attrition. The percentage of children that wore each device for between 6 and 12 h∙d-1 on 219 
1 to 7 d is presented in the Supplemental Digital Content (see Table, Supplemental Digital 220 
Content 1). Over 95% of children wore the AGhip and GAwrist for at least 12 h on a single 221 
day. Irrespective of the number of monitoring days, the percentage of children wearing both 222 
devices decreased with hours of wear, and this drop-off was more prominent for the AGhip. 223 
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For example, the difference in the proportion of children wearing the AGhip for 6 h over 3 days 224 
and those wearing it for 12 h over 3 d was -18.3%, compared to -5.8% for the GAwrist. Ten h 225 
wear time over at least 2 d has been demonstrated to provide reliable estimates of PA in 226 
population studies of older primary school aged children (27). Taking 10 h wear time as the 227 
criterion for a valid day, the decrease in children wearing the AGhip for between 1 and 7 d was 228 
80.5%, in comparison to 62.0% for the GAwrist. A similar trend was observed when the 229 
inclusion of at least one weekend day was considered. With inclusion criteria of a minimum of 230 
10 h wear on at least 3 weekdays plus a minimum of one weekend day, GAwrist non-231 
compliance (16.4%) was lower than for the AGhip (25.2%). 232 
 233 
When the number of children classified as ‘included’ as defined by commonly used wear time 234 
criteria (27) were analysed, significantly more children achieved wear time criteria when 235 
wearing the GAwrist than the AGhip for at least 9 h∙d-1 (p=.002) and 10 h∙d-1 (p=.035) on any 236 
4 d of the week (Table 2). When a weekend day was included in the criteria this level of 237 
compliance was achieved by significantly more children wearing the GAwrist than the AGhip 238 
for either 9 h∙d-1 or 10 h∙d-1 over 2, 3, and 4 week days (p=.001-.002). Average daily wear time 239 
across the different wear time criteria ranged from 15.57 to 15.82 h∙d-1 for the GAwrist, and 240 
14.18 to 14.21 h∙d-1 for the AGhip. GAwrist daily wear time was significantly higher than for 241 
the AGhip, regardless of wear time criteria applied (p<.001). Children wore the GAwrist for 242 
significantly more days than the AGhip. When a valid day was defined as at least 9 h wear, the 243 
GAwrist was worn for 5.8 d out of 7 d compared to 5.1 d for the AGhip (p<.001), and for 5.6 244 
d versus 4.9 d when 10 h wear was the criterion (p<.001). During weekdays the GAwrist was 245 
worn for 4.2 d (9 h) and 4.1 (10 h) in comparison to 3.8 d (p<.001) and 3.7 d (p<.001) 246 
respectively, for the AGhip. The GAwrist was also worn most at weekends when valid day 247 
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minimum wear was set to 9 and 10 h (GAwrist: 1.6 d and 1.5 d, respectively; AGhip: 1.3 d and 248 
1.2 d, respectively; p<.001).  249 
TABLE 2 HERE 250 
Raw data physical activity levels 251 
Significant partial correlations between raw data PA outcomes confirmed that after adjustment 252 
for wear time, SVM (r = .68), MPA (r = .81), VPA (r = .85), and MVPA (r = .83) were 253 
moderately to strongly associated between devices (p<.001). Bland-Altman plots are presented 254 
in Figure 1A-D and show that the extent of differences in SVM, MPA, VPA, and MVPA 255 
between GAwrist and AGhip increased linearly with children’s levels of PA engagement. 256 
Correlation coefficients between mean and bias were r = .75 (SVM), r = .64 (MPA), r = .75 257 
(VPA), and r = .69 (MVPA).  258 
FIGURE 1A-D HERE 259 
 260 
Comparisons of PA levels between devices are presented in Table 3. Wear time and sex-261 
adjusted SVM values during the whole week, weekdays, and weekend days were significantly 262 
higher for the GAwrist than the AGhip (p=.001). MPA recorded by the GAwrist on weekdays, 263 
weekend days, and over the whole week was 45.2% (p=.07), 41.1% (p=0.1), and 44.2% (p=.04) 264 
greater respectively, than values derived from the AGhip. GAwrist VPA was also significantly 265 
higher than AGhip at the different times of the week (p=.02 - .001), with the greatest difference 266 
of 54.7% occurring at weekends. MVPA was 43.3-45.7% greater for the GAwrist than the 267 
AGhip across the whole week, week days, and weekend days. According to the GAwrist raw 268 
data, 86.9% of children engaged in at least 60 min MVPA∙d-1, compared to 19% according to 269 
AGhip-derived MVPA.  270 
TABLE 3 HERE 271 
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Physical activity levels from AGhip raw and counts data 272 
Analyses of raw and counts data for AGhip revealed that children’s adjusted whole week MPA 273 
(raw) was 42.00 ± 1.61 min∙d-1 compared to 35.05 ± 0.99 min∙d-1 (counts) (p=.02), a difference 274 
of 16.5% (Figure 2). Adjusted VPA differed by 79.5% between counts (37.06 ± 1.85 min∙d-1) 275 
and raw data (7.59 ± 0.46 min∙d-1; p=.19). These combined MPA and VPA differences were 276 
reflected in overall MVPA (72.11 ± 2.60 min∙d-1 [counts] vs. 49.59 ± 2.01 min∙d-1 [raw]; 277 
p=.57). The recommended 60 min∙d-1 of MVPA was achieved by 20.2% and 67.7% of children 278 
with valid raw and counts data, respectively. 279 
FIGURE 2 HERE 280 
DISCUSSION 281 
In 2009 experts in PA measurement recommended that researchers’ estimations of PA should 282 
in future be based on raw acceleration data rather than proprietary movement counts (12). Since 283 
then more raw accelerometer data have been reported, but still much less frequently than counts 284 
data. This study adds to the raw accelerometer data evidence base, as it is the first to examine 285 
children’s compliance to wrist and hip-worn devices, between-device differences in PA 286 
intensities derived from raw accelerations, and differences in hip-mounted ActiGraph GT3X+ 287 
raw acceleration versus counts-based estimates of free-living PA. 288 
Accelerometer compliance 289 
More children wore the GAwrist than AGhip irrespective of the wear time inclusion criteria 290 
applied or time of week observed. Using the wrist as the accelerometer placement site may 291 
promote better device compliance, as illustrated by the improved wear time reported in the 292 
2011-12 NHANES data collection cycle (30). There is though a paucity of research 293 
investigating children’s compliance to wrist and hip-worn accelerometers worn in parallel. 294 
While it has been suggested that children (34) and adults (39) prefer the wrist as the device 295 
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placement site, such preferences may be partly dependent upon specific device features (e.g., 296 
feedback on activity (34)) and monitor-specific wear instructions (e.g., removal of hip-worn 297 
devices during sleep and water-based activities (39)). This latter point is exemplified by a 298 
recent examination of hip-worn ActiGraph data from 9-11 y olds across 12 countries, which 299 
reported how a 24 h accelerometer wear protocol resulted in an average wear time of 22.6 h 300 
REF TUDOR-LOCKE. Thus, asking children to only remove devices for water-based activities 301 
elicits much greater total wear times than are typically observed in waking time protocols. 302 
Waking wear time though was 14.7 h∙d-1 REF TUDOR-LOCKE which was similar to the 303 
AGhip values and less than the GAwrist values observed in our study. These findings confirm 304 
the combined influences of wear location and protocol on accelerometer wear compliance. To 305 
our knowledge no previous studies have examined children’s compliance to wearing wrist and 306 
hip-mounted accelerometers concurrently. Our findings confirm that children’s perceived 307 
acceptability of and preference for wrist-worn devices (34), reflect actual wear when children 308 
were asked to use two devices under the same conditions. Where feasible, future youth PA 309 
studies should employ wrist-worn accelerometry to increase the likelihood of longer wear time 310 
which would result in more representative and reliable estimates of PA (17). Wrist-worn 311 
devices may not only result in superior compliance, but according to recent evidence, may also 312 
provide better estimates of children’s energy expenditure compared to hip mounted 313 
accelerometers (7). For wrist-worn accelerometry to become widely adopted however, more 314 
needs to be known about the comparability of children’s PA levels derived from raw 315 
accelerations, with historical counts-based data.  316 
PA derived from raw acceleration signals of wrist and hip worn accelerometers 317 
Correlations between wrist-worn GENEActiv and hip-worn ActiGraph free-living raw 318 
accelerations have not previously been reported in children. We observed moderate to strong 319 
partial correlations between AGhip and GAwrist (r = .68-.85) which were lower than the 320 
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recently reported correlation of r = .93 between hip worn GENEActiv and ActiGraph GT3X+ 321 
average accelerations (29). Our findings indicate that both devices measured children’s free-322 
living accelerations which explained almost 70% of the shared variance in MVPA. 323 
Notwithstanding these strong associations, there were considerable differences between 324 
devices in average SVM and time spent in MPA, VPA, and MVPA. GAwrist values were 325 
consistently higher than those from the AGhip, particularly at higher intensities. These 326 
differences were most extreme for SVM values (~60%) which were calculated for both devices 327 
using identical data processing methods. In the only previous study to compare children’s raw 328 
GAwrist and AGhip data using the ENMO data processing approach, GAwrist SVM was 329 
significantly higher for a range of moderate-to-vigorous activities performed during a 330 
controlled device calibration protocol (i.e., fast walking, stepping, running, and circuit training) 331 
(13). Moreover, in agreement with our MPA and VPA results, greater relative differences 332 
between AGhip and GAwrist SVM values were observed as activity intensity increased (13). 333 
Similar differences between devices worn at the same site have previously been reported in 334 
adults as well as children regardless of analytical approaches used to generate raw accelerations 335 
(16, 29, 30). During vigorous ambulatory activities such as fast running, higher accelerations 336 
at the wrist relative to the hip may be observed due to greater shoulder muscle activity, 337 
compared to during walking and slow running, when arm swing and resultant wrist 338 
accelerations are more passive (31). Moreover, wrist accelerations will be disproportionately 339 
greater than those of the hip for certain types of movements that may occur regularly during 340 
children’s free-living activity (e.g., some sports, computer gaming, homework), and for 341 
example among children who gesticulate vigorously (30). This ‘decoupling’ of wrist and hip 342 
accelerations may also occur in reverse (e.g., walking with hands in pockets) and is likely 343 
population-specific (30). We did not record the children’s activity modes but it may be feasible 344 
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that their daily activities involved a disproportionate volume of ‘pro-wrist’ decoupling of wrist 345 
and hip accelerations, which contributed to higher GAwrist values. 346 
 347 
Although device location is arguably the most obvious reason why PA outcomes differed to 348 
the extent that they did, the strong inter-device associations between outcomes suggest that 349 
placement was not the only reason. Raw acceleration data from each device were used to 350 
generate the PA outcomes, but data cannot be considered equivalent (40), as raw accelerations 351 
for the GENEActiv have been observed to be greater than those for the ActiGraph GT3X+ 352 
when worn at the same site in controlled and free-living conditions (16, 29, 31). For example, 353 
during mechanical shaker testing GENEActiv peak accelerations were up to 7.4% greater than 354 
ActiGraph GT3X+ with  differences increasing in line with shaker acceleration magnitude (16). 355 
Similarly, average GENEActiv high-pass filtered accelerations were recently observed to be 356 
over 10% greater than ActiGraph GT3X+ accelerations when both devices were worn at the 357 
hip during children’s free-living activities (29). Technical differences between devices, such 358 
as the micro-electro-mechanical sensors used and their dynamic ranges, reference voltage, 359 
analogue-to-digital conversion rate, and ActiGraph’s proprietary data filtering processes (15, 360 
16, 29), are the likely explanations of the differences in each device’s acceleration outputs.  361 
 362 
Comparison of raw and counts PA data measured by a hip-mounted accelerometer 363 
Systematic differences in AGhip PA outcomes from raw and counts data were not observed. 364 
Raw data MPA values were 15.9% higher than counts data, but raw data VPA values were 365 
79.6% lower than counts data. To our knowledge, no previous study has compared hip-366 
mounted ActiGraph GT3X+ raw and counts data output in children. The closest comparison is 367 
provided by Rowlands and colleagues who compared ActiGraph GT3X+ counts data using the 368 
cutpoints of Evenson et al. (10) with GENEActiv raw data, with both devices worn at the hip 369 
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(30). The comparison is based on the very strong associations between devices for MVPA 370 
measured at the hip (r=.93) (30). Rowlands et al.’s findings mirrored ours whereby raw data 371 
MPA was greater than counts data (56.7 vs. 32.3 min∙d-1), but was lower for VPA (11.1 vs. 372 
30.0 min∙d-1) (30). The magnitude of the differences though differed somewhat, which may 373 
relate to the different raw data processing procedures and raw acceleration cutpoints (25) 374 
applied between our study and that of Rowlands and colleagues (30). It is likely that 375 
comparable raw acceleration values reported by Rowlands et al. would have been higher than 376 
those observed in our study, due to differences in raw acceleration data processing (i.e., 377 
converting acceleration negative values to their absolute, summing acceleration values per 1-s 378 
epoch) (9, 13, 25). Moreover, the PA intensity cutpoints used in both studies were derived from 379 
different calibration protocols (13, 25), which may be a more influential factor on PA outcomes 380 
than placement site or device type (30). While some inferences about output differences can be 381 
made on the basis of raw acceleration data processing, the proprietary nature of the ActiGraph 382 
GT3X+ algorithm to convert raw acceleration into counts makes similar suppositions difficult. 383 
These findings demonstrate that raw acceleration and counts data cannot be directly compared 384 
because insufficient information is available about how counts are generated. This reinforces 385 
the calls of others (14, 20, 24) for transparent raw accelerometer data processing to become the 386 
norm so as to progress the field towards equivalency of data output and better scope for 387 
comparability of findings between studies using different devices.  388 
 389 
A strength of this study is that it is the first to assess children’s free-living PA derived from 390 
raw wrist and hip accelerations using the GENEActiv and ActiGraph GT3X+ accelerometers, 391 
respectively. Further, for the first time, children’s compliance to wearing these devices 392 
concurrently over a 7-d monitoring protocol has been reported. Wearing the accelerometers in 393 
parallel standardizes possible confounding variables such as the type of PA performed during 394 
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the monitoring period (39). Raw acceleration data were processed and analysed using the same 395 
open source procedures which adds transparency and consistency to the data. The study sample 396 
was though limited to 9-10 y olds in a low socioeconomic area of England and our findings 397 
should be interpreted and applied with this in mind as free-living PA routines may be different 398 
for other age groups and for children from other areas. A further limitation is that data were 399 
collected during school term times and so may not be representative of PA during extended 400 
non-school time such as school holidays and vacations. We also did not report time spent being 401 
sedentary or in light intensity PA. Children’s sedentary time and light PA are associated with 402 
various health outcomes but presently, raw acceleration thresholds for GENEActiv and 403 
ActiGraph GT3X+ based on the ENMO metric do not exist, and so we were limited to reporting 404 
MPA, VPA, and MVPA.  405 
 406 
During free-living activity children had significantly better compliance to wearing the GAwrist 407 
than AGhip. The recognised association between duration of monitoring and reliability of PA 408 
data means that better compliance gives researchers and research users greater confidence in 409 
the PA data reported. The superior compliance of the GAwrist confirms that the wrist is a 410 
feasible accelerometer placement location in children. Raw acceleration values derived using 411 
the same data processing procedures were significantly higher for GAwrist compared to 412 
AGhip. It is unclear why these disparities occurred but it was likely a combination of the effects 413 
of placement location and technical differences between the GENEActiv and ActiGraph 414 
GT3X+. To address this, it has been recently suggested that differences in acceleration 415 
magnitude between GENEActiv and ActiGraph GT3X could be addressed by the application 416 
of an appropriate conversion factor to make values interchangeable between devices (29). For 417 
this approach to be effective standardized data processing procedures would need to be applied 418 
to the raw acceleration data collected. AGhip PA levels calculated from raw accelerations and 419 
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counts differed substantially, particularly in respect of VPA. These findings demonstrate that 420 
regardless of device placement location raw output and counts cannot be directly compared 421 
because of the lack of information about the ActiGraph proprietary filtering algorithm applied 422 
to generate counts. Raw acceleration data processing potentially enables greater transparency, 423 
and comparability between studies using the same data processing methods, though 424 
comparisons to counts-based data are limited . From a health promotion perspective, current 425 
PA guidelines are mainly based on self-report questionnaires and to a lesser extent, data from 426 
hip mounted accelerometer counts. As the use of raw acceleration data increases, examination 427 
of activity-health relationships using raw data from wrist mounted devices is warranted. We 428 
used the ENMO metric to calculate SVM but presently no SVM thresholds for children’s light 429 
PA and sedentary time exist using this method. Future work should include development of 430 
these thresholds which may help enhance our understanding of the influence of device type 431 
and placement location on children’s free-living raw accelerations and associated health 432 
outcomes. 433 
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 538 
FIGURE CAPTIONS 539 
Figure 1A-D. Bland-Altman plots displaying agreement between AGhip and GAwrist derived 540 
(A) SVM, (B) MPA, (C) VPA, and (D) MVPA. Note. The observed positive bias indicates that 541 
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GAwrist values were higher than AGhip. Horizontal lines represent mean bias and 95% limits 542 
of agreement. 543 
Figure 2. Whole week MPA and VPA according to AGhip counts and raw data (n = 65) 544 
* AGhip raw MPA > AGhip counts MPA, p=.02  545 
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